SCHEMBL5200656

SCHEMBL5200656

COC(=O)CCc1cc(F)c(F)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
MAOB P27338 1/20 0.41
ADRB2 P07550 1/20 0.40
ADRB1 P08588 1/20 0.40
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
MAPK1 P28482 1/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
HSP90AB1 P08238 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.39
PTPN1 P18031 2/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16049167 0.87 RPS6KA3 (0.45) TSHRKMT2AALDH1A1MAPTLMNA
SCHEMBL22915914 0.84 TSHR (0.39) TSHRKMT2AADRB2ADRB1ALDH1A1
SCHEMBL21275867 0.83 CA12 (0.38) TSHRKMT2AADRB2ADRB1ALDH1A1
SCHEMBL31226143 0.82 GAA (0.37) TSHRKMT2AALDH1A1MAPTLMNA
Hydrochloric Acid SCHEMBL5254248 0.81 TSHR (0.43) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL3679438 0.80 RPS6KA3 (0.39) TSHRKMT2AMEN1ALDH1A1MAPT
SCHEMBL3683799 0.80 ALOX5 (0.51) TSHRALDH1A1MAPK1PTPN1
SCHEMBL25212378 0.79 MAOB (0.36) MAOBCES2CES1
SCHEMBL584916 0.78 HTT (0.52) ALDH1A1MAPK1LMNAHTT
SCHEMBL3446879 0.78 ALDH1A1 (0.45) TSHRALDH1A1MAPTHSD17B10CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070197594-A1 Cyclic amine derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2007-08-23 US disclosed
EP-1795524-A1 CYCLIC AMINE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-06-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197594-A1 Cyclic amine derivative or salt thereof GRIN1, PARK7, GRIN3A TSHR 4386/4885KMT2A 1165/4885MEN1 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.